General Surgery Clinic, Center for Anestesiology and Reanimatology, Clinical Center in Niš, Bulevar Dr Zorana Djindjića 48, 18000, Nis, Serbia.
Department for Biochemistry, Medical School, University in Niš, Nis, Serbia.
Aging Clin Exp Res. 2018 May;30(5):419-431. doi: 10.1007/s40520-017-0805-9. Epub 2017 Jul 27.
Number of elderly patients subjected to extensive surgical procedures in the presence of cardiovascular morbidities is increasing every year. Therefore, there is a need to make preoperative diagnostics more accurate.
To evaluate the usefulness of American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) calculator as a predictive tool in preoperative assessment of cardiovascular risk in elderly patients.
This prospective pilot study included 78 patients who were being prepared for extensive non-cardiac surgeries under general anaesthesia. Their data have been processed on the interactive ACS NSQIP calculator. Blood sampling has been performed 7 days prior to surgery, and serum has been separated. Clinical, novel, and experimental biomarkers [hsCRP, H-FABP, and Survivin (BIRC5)] have been measured in specialized laboratories.
Mean age of included patients was 71.35 ± 6.89 years. In the case of heart complications and mortality prediction, hsCRP and ACS NSQIP showed the highest specificity and sensitivity with AUC, respectively, 0.869 and 0.813 for heart complications and 0.883 and 0.813 for mortality. When combined with individual biomarkers AUC of ACS NSQIP raised, but if we combined all three biomarkers with ACS NSQIP, AUC reached as much as 0.920 for heart complications and 0.939 for mortality.
ACS NSQIP proved to reduce inaccuracy in preoperative assessment, but it cannot be used independently, which has already been proved by other authors.
Our results indicate that ACS NSQIP represents an accurate tool for preoperative assessment of elderly patients, especially if combined with cardiac biomarkers.
每年有大量患有心血管疾病的老年患者接受广泛的外科手术。因此,需要使术前诊断更加准确。
评估美国外科医师学会国家外科质量改进计划(ACS NSQIP)计算器作为预测工具在老年患者心血管风险术前评估中的作用。
这项前瞻性试点研究纳入了 78 名拟接受全身麻醉下广泛非心脏手术的患者。他们的数据在互动式 ACS NSQIP 计算器上进行处理。在手术前 7 天进行了血液采样,并分离血清。在专门的实验室中测量了临床、新型和实验生物标志物[hsCRP、H-FABP 和 Survivin(BIRC5)]。
纳入患者的平均年龄为 71.35±6.89 岁。在心脏并发症和死亡率预测方面,hsCRP 和 ACS NSQIP 的特异性和敏感性最高,曲线下面积(AUC)分别为 0.869 和 0.813 用于心脏并发症,0.883 和 0.813 用于死亡率。当与个体生物标志物联合使用时,ACS NSQIP 的 AUC 升高,但如果将三种生物标志物与 ACS NSQIP 联合使用,AUC 则分别达到 0.920 用于心脏并发症和 0.939 用于死亡率。
ACS NSQIP 被证明可以减少术前评估的不准确性,但正如其他作者已经证明的那样,它不能单独使用。
我们的结果表明,ACS NSQIP 是老年患者术前评估的准确工具,尤其是与心脏生物标志物联合使用时。